GDM management during labor and delivery
Timing and mode of delivery
In the case of diabetes or GDM alone, but at the present time it cannot be said that there is sufficient data to support this. For example, it has been reported that in the case of a GDM patient undergoing insulin therapy where fetal development is thought to be within the normal range, thereis no difference in the caesarean section rate between women for whom labor is induced at 38 weeks and those for whom labor is not induced. Moreover, it has also been reported that there is no difference in the incidence of macrosomia or caesarean section between insulin-treated GDM patients for whom labor is induced at 38-39 weeks and insulin-treated GDM patients who electively waited for labor and childbirth to take their natural course.